Guangzhou Henovcom Bioscience Co. Ltd.
6 clinical trials · Sponsor
◉ Watch Guangzhou Henovcom Bioscience Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| Relative Bioavailability Study of HNC364 Injectable Suspension (NCT06798519) | Guangzhou Henovcom Bioscience Co. Ltd. | 2026-05-08 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension (NCT05523570) | Guangzhou Henovcom Bioscience Co. Ltd. | 2022-08-22 |
| A Study of HNC664 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics (NCT04504448) | Guangzhou Henovcom Bioscience Co. Ltd. | 2020-08-11 |
| A Study of HNC042 in Healthy Chinese Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics (NCT04603989) | Guangzhou Henovcom Bioscience Co. Ltd. | 2020-08-01 |
| A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics. (NCT03740555) | Guangzhou Henovcom Bioscience Co. Ltd. | 2018-11-09 |
Track Guangzhou Henovcom Bioscience Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.